| SARS-CoV-2 spike E484K mutation reduces antibody neutralisation S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, H Alshammary, ... The Lancet Microbe 2 (7), e283-e284, 2021 | 336 | 2021 |
| Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice FS Oladunni, JG Park, PA Pino, O Gonzalez, A Akhter, A Allué-Guardia, ... Nature communications 11 (1), 6122, 2020 | 251 | 2020 |
| The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, F Krammer, V Simon, ... MedRxiv, 2021 | 130 | 2021 |
| Binding of the pathogen receptor HSP90AA1 to avibirnavirus VP2 induces autophagy by inactivating the AKT-MTOR pathway B Hu, Y Zhang, L Jia, H Wu, C Fan, Y Sun, C Ye, M Liao, J Zhou Autophagy 11 (3), 503-515, 2015 | 104 | 2015 |
| Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice JA Silvas, DM Vasquez, JG Park, K Chiem, A Allué-Guardia, ... Journal of Virology 95 (17), e00402-21, 2021 | 72 | 2021 |
| Cellular chaperonin CCTγ contributes to rabies virus replication during infection J Zhang, X Wu, J Zan, Y Wu, C Ye, X Ruan, J Zhou Journal of virology 87 (13), 7608-7621, 2013 | 68 | 2013 |
| Rescue of SARS-CoV-2 from a single bacterial artificial chromosome C Ye, K Chiem, JG Park, F Oladunni, RN Platt, T Anderson, F Almazan, ... MBio 11 (5), e02168-20, 2020 | 65 | 2020 |
| Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets RM Cox, JD Wolf, CM Lieber, J Sourimant, MJ Lin, D Babusis, V DuPont, ... Nature Communications 12 (1), 6415, 2021 | 64 | 2021 |
| Inhibition of antiviral innate immunity by birnavirus VP3 protein via blockage of viral double-stranded RNA binding to the host cytoplasmic RNA detector MDA5 C Ye, L Jia, Y Sun, B Hu, L Wang, X Lu, J Zhou Journal of virology 88 (19), 11154-11165, 2014 | 59 | 2014 |
| Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters MS Piepenbrink, JG Park, FS Oladunni, A Deshpande, M Basu, S Sarkar, ... Cell Reports Medicine 2 (3), 100218, 2021 | 58 | 2021 |
| A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike M Lu, P Dravid, Y Zhang, S Trivedi, A Li, O Harder, M Kc, ... Proceedings of the National Academy of Sciences 118 (12), e2026153118, 2021 | 46 | 2021 |
| Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes K Chiem, D Morales Vasquez, JG Park, RN Platt, T Anderson, MR Walter, ... Journal of Virology 95 (7), e02209-20, 2021 | 37 | 2021 |
| Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2 JG Park, FS Oladunni, K Chiem, C Ye, M Pipenbrink, T Moran, MR Walter, ... Journal of Virological Methods 287, 113995, 2021 | 35 | 2021 |
| VP1 and VP3 are required and sufficient for translation initiation of uncapped infectious bursal disease virus genomic double-stranded RNA C Ye, Y Wang, E Zhang, X Han, Z Yu, H Liu Journal of Virology 92 (2), e01345-17, 2018 | 34 | 2018 |
| SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming CT Wu, PV Lidsky, Y Xiao, R Cheng, IT Lee, T Nakayama, S Jiang, W He, ... Cell 186 (1), 112-130. e20, 2023 | 28 | 2023 |
| SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 E Heilmann, F Costacurta, SA Moghadasi, C Ye, M Pavan, D Bassani, ... Science Translational Medicine, eabq7360, 2022 | 26 | 2022 |
| Infectious bursal disease virus activates c-Src to promote α4β1 integrin-dependent viral entry by modulating the downstream Akt-RhoA GTPase-actin rearrangement cascade C Ye, X Han, Z Yu, E Zhang, L Wang, H Liu Journal of Virology 91 (3), e01891-16, 2017 | 26 | 2017 |
| SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe 2: e283–e284 S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, F Krammer, V Simon, ... | 25 | 2021 |
| Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors SA Moghadasi, E Heilmann, AM Khalil, C Nnabuife, FL Kearns, C Ye, ... Science Advances 9 (13), eade8778, 2023 | 24 | 2023 |
| A Lassa fever live-attenuated vaccine based on codon deoptimization of the viral glycoprotein gene Y Cai, C Ye, B Cheng, A Nogales, M Iwasaki, S Yu, K Cooper, DX Liu, ... Mbio 11 (1), e00039-20, 2020 | 23 | 2020 |
